Physician profile
Patrick E Paullus
NPI 1235558487
$2,761.82
in general payments reported to CMS, 2019-2025
9 companies · $311 in 2025
The $311 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.50 · 2022: $150 · 2023: $201 · 2024: $2,087 · 2025: $311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,700 · Food and Beverage: $899.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,699.67 |
| Food and Beverage | $899.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $2,019.66 | 2021-2024 | Excelsiusgps Robotic Navigation System, Excelsius3d Imaging System, Sable |
| Stryker Corporation | $214.47 | 2024-2025 | Nico Brainpath, Nico Myriad, Core |
| Cerapedics INC. | $201.41 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Depuy Synthes Sales INC. | $94.11 | 2022 | |
| Medtronic, INC. | $66.42 | 2025 | Aquamantys(Tm), Inceptiv |
| Abbott Laboratories | $55.29 | 2024-2025 | Proclaim, Octrode |
| Innovation Technologies INC | $43.42 | 2022 | |
| Aesculap, INC. | $35.88 | 2025 | Aesculap |
| Ethicon US, LLC | $31.16 | 2024 | Ethicon, Echelon; Endopath |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Paullus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.